The protective effects of ischemic preconditioning on rats with renal ischemia-reperfusion injury and the effects on the expression of Bcl-2 and Bax

被引:24
作者
Shen, Sheng [1 ]
Zhou, Jiexue [1 ]
Meng, Shandong [1 ]
Wu, Jiaqing [1 ]
Ma, Juan [1 ]
Zhu, Chunli [1 ]
Deng, Gengguo [1 ]
Liu, Dong [1 ]
机构
[1] Guangdong Second Prov Gen Hosp, Dept Organ Transplantat, 466 Xingang Middle Rd, Guangzhou 510317, Guangdong, Peoples R China
关键词
renal ischemia-reperfusion; ischemic preconditioning; protective effect; Bcl-2; Bax; OXIDATIVE STRESS; KIDNEY-DISEASE; DAMAGE;
D O I
10.3892/etm.2017.5047
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The aim of the present study was to investigate the protective effects of ischemic preconditioning on rats with renal ischemia-reperfusion injury and the effects on the expression of Bcl-2 and Bax. Thirty-six SD rats were randomly divided into three groups (n=12) including sham operation (S) group, ischemia-reperfusion group (I/R) group and ischemic preconditioning (IP) group. After anesthesia with intraperitoneal injection of chloral hydrate, bilateral renal pedicles were clipped for 45 min, followed by perfusion for 6 h to establish the I/R model. Both kidneys in rats of S group were separated and exposed for 45 min, but renal pedicles were not clipped. In IP group, bilateral renal pedicles were clipped for 5 min, followed by perfusion for 5 min, this procedure was repeated 3 times. Then bilateral renal pedicles were clipped for 45 min, followed by perfusion for 6 h. Blood samples were collected and rats were sacrificed to collect renal tissue. Levels of serum creatinine (Cr) and blood urea nitrogen (BUN) were measured. Activity of superoxide dismutase (SOD) was measured by xanthine oxidase assay. Degree of renal injury was evaluated by H&E staining. TUNEL kit was used to detect the number of apoptotic cells in renal tissue. Expression levels of Bcl-2 and Bax were detected by semi-quantitative PCR and western blot analysis at mRNA and protein levels, respectively. Results showed that levels of Cr and BUN in I/R and IP groups were significantly higher than those in S group, and levels of Cr and BUN in I/R group were significantly higher than that in IP group (P<0.05). Activity of SOD in I/R group and IP group were significantly lower than those in S group, and activity of SOD in I/R group were significantly lower than those in IP group (P<0.05). H&E staining showed that, compared with S group, renal injury in the I/R and IP groups was more serious than that in the S group, and I/R group was more serious than the IP group (P<0.05). TUNEL apoptosis assay showed that number of apoptotic cells in IP and I/R groups were significantly higher than that in the S group (P<0.01). Semi-quantitative PCR and western blot analysis showed that, compared with the S group, expression levels of Bcl-2 mRNA and protein were significantly decreased, expression levels of Bax mRNA and protein were significantly increased, and the ratio of Bcl-2/Bax was significantly decreased in the IP and I/R groups (P<0.01). Compared with the I/R group, expression level of Bcl-2 was significantly increased, the level of Bax was significantly deceased, and the ratio of Bcl-2/Bax was significantly increased in the IP group (P<0.01). As a result, ischemic preconditioning can protect rats with renal ischemia-reperfusion injury possibly by increasing the expression level of Bcl-2 and decreasing the expression level of Bax.
引用
收藏
页码:4077 / 4082
页数:6
相关论文
共 20 条
  • [1] SOD Therapeutics: Latest Insights into Their Structure-Activity Relationships and Impact on the Cellular Redox-Based Signaling Pathways
    Batinic-Haberle, Ines
    Tovmasyan, Artak
    Roberts, Emily R. H.
    Vujaskovic, Zeljko
    Leong, Kam W.
    Spasojevic, Ivan
    [J]. ANTIOXIDANTS & REDOX SIGNALING, 2014, 20 (15) : 2372 - 2415
  • [2] Exendin-4 and sitagliptin protect kidney from ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction
    Chen, Yen-Ta
    Tsai, Tzu-Hsien
    Yang, Chih-Chau
    Sun, Cheuk-Kwan
    Chang, Li-Teh
    Chen, Hung-Hwa
    Chang, Chia-Lo
    Sung, Pei-Hsun
    Zhen, Yen-Yi
    Leu, Steve
    Chang, Hsueh-Wen
    Chen, Yung-Lung
    Yip, Hon-Kan
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11
  • [3] Chua S, 2016, J TRANSL MED, V19, P285
  • [4] Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis
    Fox, Caroline S.
    Matsushita, Kunihiro
    Woodward, Mark
    Bilo, Henk J. G.
    Chalmers, John
    Lambers Heerspink, Hiddo J.
    Lee, Brian J.
    Perkins, Robert M.
    Rossing, Peter
    Sairenchi, Toshimi
    Tonelli, Marcello
    Vassalotti, Joseph A.
    Yamagishi, Kazumasa
    Coresh, Josef
    de Jong, Paul E.
    Wen, Chi-Pang
    Nelson, Robert G.
    [J]. LANCET, 2012, 380 (9854) : 1662 - 1673
  • [5] Evaluating the Contribution of the Cause of Kidney Disease to Prognosis in CKD: Results From the Study of Heart and Renal Protection (SHARP)
    Haynes, Richard
    Staplin, Natalie
    Emberson, Jonathan
    Herrington, William G.
    Tomson, Charles
    Agodoa, Lawrence
    Tesar, Vladimir
    Levin, Adeera
    Lewis, David
    Reith, Christina
    Baigent, Colin
    Landray, Martin J.
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2014, 64 (01) : 40 - 48
  • [6] Huang P, 2016, INT J MOL SCI, V206, P26
  • [7] Kierulf-Lassen C, 2016, BMC CANCER, V16, P686
  • [8] Automated Segmentation of Kidneys from MR Images in Patients with Autosomal Dominant Polycystic Kidney Disease
    Kim, Youngwoo
    Ge, Yinghui
    Tao, Cheng
    Zhu, Jianbing
    Chapman, Arlene B.
    Torres, Vicente E.
    Yu, Alan S. L.
    Mrug, Michal
    Bennett, William M.
    Flessner, Michael F.
    Landsittel, Doug P.
    Bae, Kyongtae T.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 11 (04): : 576 - 584
  • [9] The Effect of Dexmedetomidine on Oxidative Stress Response Following Cerebral Ischemia-Reperfusion in Rats and the Expression of Intracellular Adhesion Molecule-1 (ICAM-1) and S100B
    Li, Yanwen
    Liu, Shikun
    [J]. MEDICAL SCIENCE MONITOR, 2017, 23 : 867 - 873
  • [10] Lindqvist LM, 2016, INVEST NEW DRUGS, V34, P713